Biotie Therapies Corp. (“Biotie” or the “Company”) has conveyed 15,000 Biotie shares held as treasury shares pursuant to the Stock Option Plan 2011.
After this conveyance, all 3,321,660 shares issued on 2 January 2014 and held in treasury for this purpose have been conveyed. Under the Stock Option Plan 2011, the owners of the stock options may subscribe for a maximum total of 7,401,000 shares and the owners of the Equity Incentive Plan 2011 may subscribe for a maximum total of 4,599,000 shares in the Company. Due to share issues already made pursuant to the Stock Option Plan 2011 and the Equity Incentive Plan 2011 (the “Plans”), forfeitures and some of the instruments based on the Plans having been left unallocated, a maximum of 5,472,375 shares may still be issued pursuant to the Plans.
The subscription price of EUR 0.01 per share has been fully paid by the employee and the EUR 150 funds received for the conveyance made will be credited to the Company’s reserve for non-restricted equity.
The conveyed shares previously held as treasury shares have not carried any voting rights. The conveyance does not affect the number of registered shares. After the conveyances the changes are as follows:
Increase in number Total amount of Number of the Total number of outstanding voting rights Company’s share held of registered shares by the Group shares 15,000 450,696,015 5,336,383 456,032,398
Turku, 17 December 2014
Biotie Therapies Corp.
Timo Veromaa, President and CEO
For further information, please contact:
Virve Nurmi, Investor Relations Manager, Biotie Therapies Corp.
tel. +358 2 274 8900, e-mail: virve.nurmi@biotie.com
Help employers find you! Check out all the jobs and post your resume.
